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Background: In response to the COVID-19 pandemic, many countries mandated staying at 
home to reduce transmission. This study examined the association between living 
arrangements (house occupancy numbers) and outcomes in COVID-19. 
Methods: Study population was drawn from the COPE Study, a multicentre cohort study. 
House occupancy was defined as: living alone; living with one other person; living with multiple 
other people; or living in a nursing/residential home. Outcomes were time from admission to 
mortality and discharge (Cox regression), and Day-28 mortality (logistic regression), analyses 
were adjusted for key comorbidities and covariates including admission: age; sex, smoking; 
heart failure; admission CRP; COPD; eGFR, frailty and others.  
Results: 1584 patients were included from 13 hospitals across UK and Italy: 676 (42.7%) were 
female, 907 (57.3%) were male, median age was 74 years (range: 19-101). At 28 days, 502 
(31.7%) had died. Median admission CRP was 67, 82, 79.5 and 83mg/L for those living alone, 
with someone else, in a house of multiple occupancy and in a nursing/residential home, 
respectively. Compared to living alone, living with anyone was associated with increased 
mortality: within a couple (aHR 1.39, 95%CI 1.09-1.77, p=0.007); living in a house of multiple 
occupancy (aHR=1.67, 95%CI 1.17-2.38, p=0.005); and living in a residential home (aHR=1.36, 
95%CI  1.03-1.80, p=0.031). 
Conclusion: For patients hospitalised with COVID-19, those living with one or more people 
had an increased association with mortality, they also exhibited higher CRP indicating increased 
disease severity suggesting they delayed seeking care.
Key Words: Covid-19; Coronavirus; Multiple House occupancy
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The Covid-19 pandemic has provided one of the greatest challenges known to public health. As 
of 15th December 2020, there have been over 70 million cases and 1.6 million deaths attributed 
to the virus worldwide [1]. Transmission of the SARS- CoV- 2 virus is dependent on human 
interaction and behaviours, and this has been the single most important public health target 
across the globe [2]. In addition to handwashing [3] and the use of face- coverings [4], the public 
have been encouraged to physically distance and “Stay at Home” throughout. Furthermore, 
current UK law requires people to self- isolate if they or someone they live with are symptomatic 
or have a positive test [5]. More specifically, those infected with Covid-19 who live with another 
person or in a house of multiple occupancy are advised to self-isolate within their homes 
separate from other household members. This has been effective from a public health 
perspective in suppressing transmission of the virus. 
However, it is not known whether outcomes in Covid-19 disease may be affected by social 
determinants such as living arrangements. Whilst isolation measures may reduce transmission, 
evidence is lacking with regard to how the environment in which people are isolating impacts on 
the severity of disease and outcomes for individuals who have contracted Covid-19.  There has 
been no study to date that examines patient outcomes in relation to house occupancy. The 
primary aim of this study is to examine the association between living arrangements and in-
hospital mortality in patients with Covid-19 infection, the secondary aim was to assess 
occupancy on time-to-discharge and disease severity estimated by serum CRP levels.  
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Data were collated as part of a European multicentre observational study: COPE (COVID-19 in 
Older People study) [6]. The protocol has been published elsewhere [7]. Ethical approval was 
obtained in the UK by the Health Research Authority (20/HRA/1898) and the Ethics Committee 
of Policlinico Hospital Modena, Italy (369/2020/OSS/AOUMO), respectively. This study has been 
reported following the STROBE statement [8]. A central MACRO database, hosted by King’s 
Clinical Trials Unit (KCTU), was used to collate the data centrally.
Setting
The study sites included an established network of twelve UK sites and one Italian site. The UK 
centres included: Aberdeen Royal Infirmary, Glasgow Royal Infirmary, Inverclyde Royal 
Hospital, Maidstone Hospital, Nevill Hall Hospital in Abergavenny, Royal Alexandra Hospital in 
Paisley, Royal Gwent Hospital in Newport, Southmead Hospital in Bristol, Salford Royal 
Hospital, University Hospital of Wales in Cardiff, Ysbyty Gwynedd in Bangor, and Ysbyty Ystrad 
Fawr in Caerphilly. The Italian centre was the University Hospital of Modena Policlinico. 
Participants
Each site research team screened hospital admission lists daily between 27th February and 10th 
June 2020. The ethical approval was such that formal written consent from participants was not 
required as all data were routinely collected in hospital records.
Inclusion/exclusion criteria
The study included consecutive hospitalised adult patients aged 18 years or older with a 
confirmed diagnosis of COVID-19 admitted between 27th February and 10th June 2020; 
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diagnostic criteria included laboratory confirmed SARS-CoV-2 positive swab or a clinical 
diagnosis of COVID-19; patients needed to be followed up at least for 28 days or until death. 
Outcome
The primary outcome was length of time from admission to mortality. Secondary outcomes were 
the time-to-discharge, and Day 28 mortality. Patients who were discharged prior to Day 28 were 
censored at this point in the time to mortality analysis and assumed to be alive in the Day 28 
mortality analysis, and those died were censored in the time to discharge analysis. Those alive 
and still in hospital with less than 28 days follow up were excluded from the Day 28 mortality 
analysis. For patients diagnosed with Covid-19 whilst as an inpatient the date of diagnosis was 
used rather than date of admission to hospital. Other prespecified outcomes included in the 
COPE study were the effect of drug classes, nosocomial infection and frailty, however these are 
not analysed here and have been reported in previous publications [6,9-11].  
Primary exposure 
Home occupancy was categorised as: living alone; living with one other person; living in a 
house of multiple occupancy (not in a residential or nursing home); living in a residential or 
nursing care home.  
Covariates 
Demographic and clinical characteristics recorded at admission were: age, sex, smoking status 
(never, previous, or current), C-reactive protein (CRP) as a marker of disease severity (REF 
Stringer et al, under revision with Int J Epidemiol), estimated glomerular filtration rate (eGFR), 
previous history of coronary artery disease (CAD), diabetes mellitus, chronic obstructive 
pulmonary disease (COPD), hypertension (no, yes not on treatment, and yes on treatment), 
albumin, heart failure, and frailty (using the Clinical Frailty Scale; CFS).
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Admission demographic and clinical characteristics were presented by Day-28 mortality, to 
describe the included participant characteristics. 
Time to mortality (primary outcome) and length of stay (secondary outcome) were analysed with 
mixed-effects multivariable Cox’s proportional baseline hazards regression models. The 
analyses were fitted with a random effect to account for hospital variation (26), and adjusted for 
the base model of: patient age group; sex; smoking status; CRP; diabetes; hypertension; eGFR; 
COPD; coronary artery disease (CAD); albumin; heart failure; and frailty (CFS; 1-3 versus 4-5 
and 6-9). The adjusted hazard ratios (aHR) were estimated with associated 95% confidence 
intervals (95% CI). The baseline proportionality assumption was tested visually with log-log 
residuals. Each time to event analysis was reported with a Kaplan Meier survival plot. 
The secondary outcome of Day-28 mortality was analysed using a mixed-effects multivariable 
logistic model, fitting each hospital as a random intercept effect, and adjusted with covariates 
consistent with the primary outcome. The adjusted odds ratio (aOR) were presented with 
associated 95% CI. Missing data were explored for patterns of missingness. Analysis was 
carried out using Stata/MP version 16.0.
Deprivation, using the Index of Multiple Deprivation (IMD 1-3 versus 4-7 and 8-10) was 
additionally fitted to the primary analysis of the mixed-effects multivariable Cox PH analysis as a 
sensitivity analysis.
Results 
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The study included 1671 patients from 13 hospitals; however, 87 (5.2%) did not have 28 days 
follow up (or mortality) and were excluded. Of the 1584 included patients, 676 (42.7%) were 
female, 907 (57.3%) were male, and median age was 74 years (IQR: 61.5-83; range: 19-101), 
and 1417 (89.5%) were white (Table 1). With regard to co-morbidites, 38.5% were taking 
medication for hypertension, and 60.0% had low albumin. In hospital mortality in patients with at 
least 28 day follow up (or who died) was 31.7% (502/1584). There were 433 patients who lived 
alone and 32.1% died, compared to 29.4% who died and lived with one other. Of 189 patients 
that lived in house of multiple occupancy outside of a nursing or residential home 25.4% died, 
compared to 47.0% who lived in a nursing or residential home. There were 141 cases (8.9%) 
where housing occupancy was not reported.
The Kaplan Meier overall survival plot demonstrates the association between residential or 
nursing care and mortality (Figure 1). However, little differences are suggested from the other 
three house occupancy groups. The demographic and clinical characteristics of the house 
occupancy distribution shows that patients who live alone were more likely to be older, than 
those living in a couple of in a house of multiple occupancy (Supplementary Table 1). The 
admission CRP for those living alone was median=67 mg/L (28-130 IQR), compared to those 
living as a couple, median=82 mg/L (34-155 IQR), or living in a house of multiple occupancy 
median=79.5 mg/L (45-150 IQR) or living in a nursing home median CRP=83 mg/L (35-138 
IQR).
Data Analysis
Within the crude mixed-effects Cox regression analysis, there was an association between living 
alone versus living in a care home, and mortality HR=1.60 (95% CI 1.24-2.05; p<0.001), the full 
set of crude analyses can be found in Table 2.
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Within the adjusted multivariable Cox regression, house occupancy was associated with 
mortality. Compared to living alone, co-habiting was associated with increased mortality such 
as: within in a couple (aHR1.39, 95% CI 1.09-1.77, p=0.007); living in a house of multiple 
occupancy (aHR=1.67, 95% CI 1.17-2.38, p=0.005); and living in a nursing or residential home 
(aHR=1.36, 95% CI 1.03-1.80, p=0.031). Other important covariates in the associated with 
mortality in the adjusted analysis were: age; CRP; eGFR, albumin, and COPD, full details can 
be found in Table 2. 
In the secondary outcome 28 Day mortality, occupancy was associated with mortality for 
patients in a nursing or residential home OR=1.88 (95% CI 1.34-2.64, p<0.001), Table 3. Other 
covariates associated with morality in this outcome were age, smoking, CAD, CRP, eGFR, 
albumin, COPD and CHF, Table 3. In the secondary outcome of time to discharge there was a 
crude association between having someone at home and increased discharge (compared to 
living alone), living as a couple HR=1.31 95% CI 1.11-1.55, p=0.002; and living with multiple 
others HR=1.56 95% CI 1.25-1.95, p<0.001), Supplementary Table 2. In the adjusted 
multivariable analysis there was an association between living alone verses in a 
residential/nursing home, and time to discharge (aHR=1.41 95% CI 1.08-1.84, p=0.012).
After additionally adjusting for deprivation using the Index of Multiple Deprivation (IMD 1-3, 
versus 4-7, and 8-10), there was no change in the effect of occupancy, and both the magnitude 
and significance of each finding were maintained.
Discussion
Our study reports the novel association between home living arrangements and outcomes in 
hospitalized patients with Covid-19. In this large prospective study, we have provided further 
evidence on the association of residential/ care home living and increased mortality from the 
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disease. However, we also present the novel finding that multiple house occupancy (i.e. living 
with either one or multiple other people) is associated with increased mortality in Covid-19 
infection in community settings. 
The association between nursing home residence and mortality in Covid-19 is well described. 
Although less than 0.5% of the total population of the United States live in nursing homes, 
nursing home residents have accounted for around 25% of the documented deaths in Covid-19 
[12]. A number of American states published their individual data during the early months of the 
pandemic. This has shown that deaths in long term care facilities have accounted for over 50% 
of all Covid-19 deaths in the states of Delaware, Massachusetts, Oregon, Pennsylvania, 
Colorado and Utah [13]. 
Our findings may be explained by the effect of public health messages delaying individual 
patients presenting to hospital. If incapacitated by the virus, those living alone may be less able 
to cope with their symptoms and the difficulties caused by self-isolation, therefore more likely to 
exhibit health seeking behaviour and thus present to hospital earlier with less severe disease. 
This could explain the lower admission CRP levels and subsequent lower mortality risk seen in 
this patient group. Conversely, those living with others may be encouraged to remain at home 
for longer despite a worsening clinical state and are possible to do so by support of other 
household members. 
There are a number of plausible theories that may explain the observed associations we found. 
A large prospective study has shown an independent relationship between high viral load and 
mortality, adjusted for age, sex and common comorbidities [14]. If this evidence is considered in 
the context of living arrangements, those who live with others are at risk of contracting the virus 
from another member of their household. In the lockdown climate of the early pandemic (when 
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COPE was conducted), the public health message to stay at home rendered many households 
isolating together, exposing other members of the household to the virus if one were to contract 
it. It is therefore possible that those living in houses of multiple occupancy have increased viral 
load exposure and resultant increased mortality outcomes from Covid-19. Multiple house 
occupancy was also seen to be associated with raised CRP at admission, which can be 
interpreted as a proxy for increased disease severity [15]. This is clinically relevant to public 
health policy makers. The message should be very clear, that strict self-isolation for Covid-19 
positive people within houses of multiple occupancy is vital in order to reduce virus exposure to 
other members of the household. It may be advisable to consider living alone as a vulnerable 
person to reduce risk of developing severe disease.
Indeed, these theories are supported by knowledge of health seeking behaviours and how they 
have been shaped by the Covid-19 pandemic. Fear and threat are central to the emotional 
responses felt by many during a pandemic [16]. Negative framing of the pandemic from the 
media’s perspective often fuels this, for example by reporting the number of cases and deaths 
rather than the data on those who recover. Those who are not mathematically skilled with 
knowledge regarding probabilities and risk are particularly susceptible to fear as a result of 
negative framing [17]. Fear and strict adherence to public health instruction to stay at home may 
have encouraged people to keep their unwell family members at home until they deteriorate to 
extremis. This could account for higher admission CRP and mortality risk in those from houses 
of multiple occupancy, observed in this study. 
This was an observational study and is therefore is subject to the intrinsic limitations associated 
with all studies of this nature. The prospective nature of the data collection reduces the 
possibility of reverse causality, and the collection of unselected and consecutive data for all 
patients admitted with Covid-19 acts to reduce selection bias. The study was limited to those 
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hospitalized, it also does not capture data from patients who remained in the community or 
patients who were discharged from (or died) in the Emergency Department. The impact of 
confounding variables has also been addressed by statistical adjustment for variables including 
age, co-morbidities and admission CRP. Patients with nosocomial Covid-19 infection (infection 
that is acquired by a patient who was admitted for another reason) were a small percentage of 
the study population, and are unlikely to impact on the results as they have been found to have 
a lower mortality rate than patients with community acquired infection [11].  We did not collect 
the duration of symptoms prior to admission and also did not collect the isolation arrangements 
between household members since onset of the symptoms, but this is of less relevance as it is 
well known that infectivity begins prior to symptom onset. We did not contact trace to household 
members and thus unable to uncertain to an extent that findings are contributed by infection 
from other household member who did not require hospital admission but contributed to 
potentially higher viral load depicted by higher CRP levels among those from homes with 
multiple occupancy. Information regarding dependency was not collected, and therefore it is 
also possible that these findings are confounded by the possibility that those people in houses 
of multiple occupancy are dependent and therefore at risk of worse outcomes. The analyses did 
not adjust for ethnicity because the majority of the sample was white (89.5%), therefore an 
analysis of ethnicity would be underpowered. We did not collect the detailed information on the 
treatment received by patients, but at the time of the study, the understanding of treatment of 
COVID-19 was sparse, and all centres are likely to have had similar approaches in 
management. 
We found these patients from multiple occupancy households to have increased levels of CRP 
at time of presentation, a proxy marker for disease severity. This is novel information into the 
impact of living arrangements and outcomes in Covid-19 disease, during a pandemic where 
there has been much uncertainty. Public health measures, although effective at preventing 
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overall disease transmission, should further highlight the importance of self-isolation within a 
household to reduce the possible effect of increased viral load. Messages should also 
encourage patients who are clinically deteriorating at home to present to hospital for appropriate 
treatment. We believe that the implications of these findings are relevant not only to the second 
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Key Points
 Multiple house occupancy (i.e. living with either one or multiple other people) is 
associated with increased mortality in Covid-19 infection in community settings.
 Patients from multiple occupancy households to have increased levels of CRP at time of 
presentation, a proxy marker for disease severity.
 Mortality risk in COVID-19 is multi-factorial and should be considered in the context of 
environmental circumstances as well as clinical and demographic variables. 
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Table 1. Demographics and comorbidities for the included patients
Mortality at Day 28
Alive Dead Total
N = 1,082 N = 502 N = 1584
Sex
Female 468 (69.2) 208 (30.8) 676 (42.7)
Male 613 (67.6) 294 (32.4) 907 (57.3)
Missing 1 0 1
Age
≤64 420 (87.3) 61 (12.7) 481 (30.4)
65–74 221 (70.8) 91 (29.2) 312 (19.7)
75–84 257 (57.1) 193 (42.9) 450 (28.4)
85+ 184 (54.0) 157 (46.0) 341 (21.5)
Ethnicity
White 957 (67.5) 460 (32.5) 1417 (89.5)
Asian/Asian British 32 (68.1) 15 (31.9) 47 (3.0)
Black/Black British 17 (77.3) 5 (22.7) 22 (1.4)
Chinese 3 (75.0) 1 (25.0) 4 (0.3)
Mixed 1 (100.0) 0 (0.0) 1 (0.1)
Other 11 (91.7) 1 (8.3) 12 (0.8)
Missing 61 20 81
Living arrangement
Lives alone 294 (67.9) 139 (32.1) 433 (27.3)
Lives with 1 other 425 (70.6) 177 (29.4) 602 (38)
Lives with multiple others (not 
in a residential or nursing 
home)
141 (74.6) 48 (25.4) 189 (11.9)
Lives with multiple others (in a 
residential or nursing home) 116 (53.0) 103 (47.0) 219 (13.8)
Missing 106 35 141
Smoking 
Never smoked 587 (71.2) 237 (28.8) 824 (52.0)
Ex-smoker 381 (63.0) 224 (37.0) 605 (38.2)
Current smoker 85 (75.9) 27 (24.1) 112 (7.1)
Missing 29 14 43
Diabetes
No 812 (69.7) 353 (30.3) 1165 (73.6)
Yes 268 (64.4) 148 (35.6) 416 (26.3)
Missing 2 1 3
Coronary Artery Disease
No 896 (71.6) 356 (28.4) 1252 (79.0)
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Yes 185 (56.1) 145 (43.9) 330 (20.8)
Missing 1 1 2
Hypertension
No 560 (70.1) 239 (29.9) 799 (50.4)
Yes 112 (64.7) 61 (35.3) 173 (10.9)
Yes (on treatment) 409 (67.2) 200 (32.8) 609 (38.5)
Missing 1 2 3
CRP
<40 380 (82.3) 82 (17.8) 462 (29.2)
≥40 689 (62.9) 406 (37.1) 1095 (69.1)
Missing 13 14 27
eGFR
≥60 745 (75.7) 239 (24.3) 984 (62.1)
45–59 120 (61.5) 75 (38.5) 195 (12.3)
30–44 105 (54.4) 88 (45.6) 193 (12.2)
<30 91 (53.9) 78 (46.2) 169 (10.7)
Missing 21 22 43
Albumin
≥35 425 (76.2) 133 (23.8) 558 (35.2)
<35 606 (63.7) 345 (36.3) 951 (60.0)
Missing 51 24 75
COPD
No 914 (70.1) 390 (29.9) 1304 (82.3)
Yes 116 (57.7) 85 (42.3) 201 (12.7)
Missing 52 27 79
Heart Failure
No 940 (70.4) 396 (29.6) 1336 (84.3)
Yes 90 (54.2) 76 (45.8) 166 (10.5)
Missing 52 30 82
Clinical Frailty Scale
1-3 468 (83.4) 93 (16.6) 561 (35.4)
4-5 257 (68.2) 120 (31.8) 377 (23.8)
6-9 351 (55.3) 284 (44.7) 635 (40.0)
Missing 6 5 11
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Table 2. Crude and Multivariable Cox proportional hazards regression presenting crude, 
and adjusted& Hazard Ratio (HR) analysis of the time to mortality
Crude HR (95% 
CI) p value 
Adjusted HR& (95% 
CI) p value
Sex
Female Reference Reference 
Male 1.05 (0.88-1.25) 0.579 1.21 (0.99-1.48) 0.060
Age
<65 Reference Reference 
65–74 2.33 (1.70-3.20) <0.001 1.85 (1.47-2.68) 0.001
75–84 3.68 (2.78-4.88) <0.001 2.93 (2.04-4.21) <0.001
85+ 3.85 (2.88-5.14) <0.001 3.08 (2.10-4.54) <0.001
Smoking 
Never smoked Reference Reference 
Ex-smoker 1.26 (1.05-1.50) 0.012 1.00 (0.82-1.24) 0.867
Current smoker 0.76 (0.51-1.12) 0.169 0.93 (0.61-1.41) 0.725
Diabetes
No Reference Reference 
Yes 1.11 (0.92-1.34) 0.288 1.05 (0.85-1.30) 0.630
Coronary Artery 
Disease
No Reference Reference 
Yes 1.57 (1.29-1.90) <0.001 1.13 (0.90-1.41) 0.307
Hypertension
No Reference Reference 
Yes 1.12 (0.85-1.49) 0.412 0.90 (0.66-1.24) 0.522
Yes (on treatment) 1.15 (0.95-1.38) 0.150 0.91 (0.74-1.13) 0.414
CRP
<40 Reference Reference 
≥40 1.92 (1.55-2.38) <0.001 2.04 (1.61-2.60) <0.001
eGFR
≥60 Reference Reference 
45–59 1.77 (1.37-2.29) <0.001 1.48 (1.12-1.95) 0.006
30–44 2.06 (1.62-2.62) <0.001 1.48 (1.13-1.95) 0.004
<30 1.83 (1.42-2.37) <0.001 1.50 (1.13-1.97) 0.004
Albumin
≥35 Reference Reference 
<35 1.45 (1.17-1.78) 0.001 1.34 (1.06-1.70) 0.014
COPD
No Reference Reference
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Yes 1.58 (1.26-1.99) <0.001 1.31 (1.01-1.70) 0.039
Heart Failure
No Reference Reference 




4-5 1.70 (1.30-2.21) <0.001 1.18 (0.86-1.64) 0.307
6-9 2.45 (1.94-3.11) <0.001 1.49 (1.09-2.05) 0.013
Living 
arrangement
Lives alone Reference Reference 
Lives with 1 other 1.05 (0.84-1.31) 0.691 1.39 (1.09-1.77) 0.007
Lives with multiple 
others (not in a 
residential or 
nursing home)
0.97 (0.69-1.34) 0.836 1.67 (1.17-2.38) 0.005
Lives with multiple 
others (in a 
residential or 
nursing home)
1.60 (1.24-2.05) <0.001 1.36 (1.03-1.80) 0.031
&Multivariable analysis was adjusted by: sex; age; smoking; diabetes; coronary artery disease; 
hypertension; CRP; eGFR; albumin, COPD, heart failure and Clinical frailty Scale.
Note: the number of observations excluded due to missing data was 227
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Table 3. Crude and Multivariable Logistic regression presenting crude, and adjusted 
multivariable& odds ratio (OR) for mortality at Day 28
Crude OR (95% 
CI) p value 
Adjusted OR& 
(95% CI) p value
Sex
Female Reference Reference 
Male 1.12 (0.90-1.40) 0.310 1.44 (1.09-1.90) 0.010
Age
≤64 Reference Reference 
65–74 3.28 (2.26-4.76) <0.001 2.17 (1.38-3.39) 0.001
75–84 6.26 (4.43-8.83) <0.001 4.20 (2.69-6.55) <0.001
85+ 7.53 (5.22-10.87) <0.001 4.96 (3.03-8.12) <0.001
Smoking 
Never 
smoked Reference Reference 
Ex-smoker 1.43 (1.14-1.79) 0.002 1.06 (0.79-1.42) 0.690
Current 
smoker 0.72 (0.45-1.15) 0.174 0.99 (0.57-1.75) 0.985
Diabetes
No Reference Reference 




No Reference Reference 
Yes 1.97 (1.52-2.55) <0.001 1.17 (0.84-1.61) 0.349
Hypertension
No Reference Reference 
Yes 1.21 (0.84-1.73) 0.306 0.80 (0.51-1.25) 0.322
Yes (on 
treatment) 1.24 (0.98-1.57) 0.075 0.94 (0.69-1.26) 0.661
CRP
<40 Reference Reference 
≥40 2.50 (1.92-3.25) <0.001 2.60 (1.90-3.56) <0.001
eGFR
≥60 Reference Reference 
45–59 2.05 (1.47-2.87) <0.001 1.38 (0.94-2.03) 0.098
30–44 2.62 (1.89-3.64) <0.001 1.41 (0.95-2.10) 0.087
<30 2.46 (1.74-3.47) <0.001 1.81 (1.19-2.73) 0.005
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≥35 Reference Reference 
<35 2.35 (1.79-3.08) <0.001 1.88 (1.36-2.60) <0.001
COPD
No Reference Reference
Yes 1.72 (1.26-2.35) 0.001 1.32 (0.90-1.95) 0.155
Heart Failure
No Reference Reference 
Yes 2.07 (1.47-2.90) <0.001 1.08 (0.72-1.64) 0.698
Frailty
1-3 Reference Reference
4-5 2.37 (1.72-3.26) <0.001 1.29 (0.86-1.94) 0.226
6-9 4.46 (3.32-5.99) <0.001 2.26 (1.51-3.41) <0.001
Living 
arrangement
Lives alone Reference Reference 
Lives with 1 
other 0.91 (0.69-1.20) 0.505 1.34 (0.97-1.87) 0.077
Lives with 
multiple 




0.70 (0.47-1.05) 0.085 1.46 (0.90-2.35) 0.121
Lives with 
multiple 




1.88 (1.34-2.64) <0.001 1.37 (0.91-2.06) 0.134
&Multivariable analysis was adjusted by: age; sex; smoking; diabetes; coronary artery disease; 
hypertension; CRP; eGFR; albumin, COPD, heart failure and frailty.
Note: the number of observations excluded due to missing data was 227
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